Skip to main content
Akron Children's > For Healthcare Professionals > Providers > Continuing Professional Development

Grand Rounds: Review and Treatment Systemic of Lupus Erythematous

06-26-2026

By Christopher Costin, MD , Pediatric Rheumatologist, Akron Children's

Rheumatology

More about Christopher Costin, MD

Objectives (Educational Content) :

1. Discuss the diagnosis and different forms of Lupus

2. Explore the pathogenesis of Lupus

3. Highlight current and emerging treatment options

Target Audience:

General pediatricians, family physicians, nurse practitioners, physician assistants, social workers, psychologists, and nurses.

Identified Gap:

There is a persistent gap between current clinical practice and optimal, evidence-based management of systemic lupus erythematosus (SLE), as clinicians often face challenges in accurately diagnosing its diverse forms, understanding its complex pathogenesis, and consistently applying evolving treatment strategies. Variability in recognizing disease manifestations can delay diagnosis, while limited familiarity with immunologic mechanisms and emerging therapies contributes to suboptimal use of targeted treatments. As a result, patients may not receive the most appropriate or timely care. This activity addresses these gaps by enhancing clinician knowledge, competence, and performance in diagnosing SLE and integrating current and emerging therapies into practice to improve patient outcomes.

Estimated Time to Complete the Educational Activity:

1 hour(s)

Expiration Date for CE/CME Credit:

06-25-2027

Method of Participation in the Learning Process:

The learner will view the presentation, successfully complete a post-test and complete an activity evaluation.

Evaluation Methods:

All learners must successfully complete a post-test, as well as an activity evaluation, to claim CE/CME credit.

Disclosure:

The speaker(s) has returned the disclosure form, indicating that there are no financial relationships with ineligible companies: Christopher Costin, MD The following CME Committee/Planning Committee member(s) has the following financial relationships with ineligible companies to disclose: Merck - Maria Cristina Victorio, MD All financial relationships have been mitigated. All remaining CME and planning committee members have returned their disclosure forms, indicating that they have no financial relationships with ineligible companies.

Accreditation Statement:

Children’s Hospital Medical Center of Akron is accredited by the Ohio State Medical Association to provide continuing medical education for physicians.

CHMCA designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit TM.  Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Bibliography:

1. Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365(22):2110-2121.

2. Kaul A, Gordon C, Crow MK, et al. Systemic lupus erythematosus. Nat Rev Dis Primers. 2016;2:16039.

3. Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008;358(9):929-939.

4. Hiraki LT, Benseler SM, Tyrrell PN, Hebert D, Harvey E. Clinical and laboratory features and long-term outcome of pediatric systemic lupus erythematosus. J Pediatr. 2008;152(4):550-556.

5. Ambrose N, Morgan TA, Galloway J, et al. Differences in disease characteristics between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2016;68(1):76-82.

6. Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the SLICC classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677-2686.

Watch Videos

Back to top of page

By using this site, you consent to our use of cookies. To learn more, read our privacy policy.